ELVN - Enliven Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$69.20
DETAILS
HIGH:
$80.00
LOW:
$59.00
MEDIAN:
$65.00
CONSENSUS:
$69.20
UPSIDE:
35.45%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 193,531 | $7.6M | 0.0% | +193,531 | NEW |
| Wood | 39,600 | $1.6M | 0.0% | -1,465,001 | DECREASED |
| Druckenmiller | 0 | $0 | -- | -- | SOLD |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-07-06 | Kunkel Lori Anne | director | SELL | 4,111 | $49.98 | $205K |
| 2026-07-06 | Kunkel Lori Anne | director | SELL | 5,889 | $50.84 | $299K |
| 2026-06-22 | ORBIMED ADVISORS LLC | 10 percent owner | SELL | 24,846 | $45.38 | $1.1M |
| 2026-06-22 | ORBIMED ADVISORS LLC | 10 percent owner | SELL | 46,776 | $45.00 | $2.1M |
| 2026-06-22 | ORBIMED ADVISORS LLC | 10 percent owner | SELL | 787,024 | $45.38 | $35.7M |
| 2026-06-22 | ORBIMED ADVISORS LLC | 10 percent owner | SELL | 1,477 | $45.00 | $66K |
| 2026-06-17 | Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | M-Exempt | 6,018 | $2.48 | $15K |
| 2026-06-17 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | M-Exempt | 5,000 | $2.48 | $12K |
| 2026-06-17 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | SELL | 2,599 | $43.87 | $114K |
| 2026-06-17 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | SELL | 1,133 | $44.74 | $51K |
| 2026-06-17 | Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | SELL | 1,379 | $42.78 | $59K |
| 2026-06-17 | Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | SELL | 3,401 | $43.86 | $149K |
| 2026-06-17 | Hohl Benjamin | officer: CHIEF FINANCIAL OFFICER | SELL | 1,238 | $44.75 | $55K |
| 2026-06-17 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | SELL | 1,268 | $42.83 | $54K |
| 2026-06-15 | ORBIMED ADVISORS LLC | 10 percent owner | SELL | 272,322 | $45.02 | $12.3M |
| 2026-06-15 | ORBIMED ADVISORS LLC | 10 percent owner | SELL | 9,086 | $45.02 | $409K |
| 2026-06-05 | Kunkel Lori Anne | director | SELL | 7,779 | $34.28 | $267K |
| 2026-06-05 | Kunkel Lori Anne | director | SELL | 354 | $35.82 | $13K |
| 2026-06-05 | Kunkel Lori Anne | director | SELL | 1,867 | $35.36 | $66K |
| 2026-05-18 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | M-Exempt | 5,000 | $2.48 | $12K |
| 2026-05-18 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | SELL | 3,475 | $39.53 | $137K |
| 2026-05-18 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | SELL | 1,302 | $40.25 | $52K |
| 2026-05-18 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | SELL | 223 | $41.21 | $9K |
| 2026-04-17 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | SELL | 140 | $45.81 | $6K |
| 2026-04-17 | Collins Helen Louise | officer: CHIEF MEDICAL OFFICER | SELL | 2,419 | $47.39 | $115K |